Detection and identification of tumor‐associated protein variants in human hepatocellular carcinomas

The proteomic approach is a valuable tool to detect and identify proteins that are associated with cancer. In previous investigations on experimentally induced rat hepatomas, we detected aldose reductase‐like protein (ARLP) as a highly significant marker protein. Our present study was intended to look for the presence of similar tumor‐associated marker proteins on human hepatocellular carcinomas (HCC). We found several novel tumor‐associated protein variants that represent members of the aldo‐keto reductase (AKR) superfamily. Human aldose reductase‐like protein‐1 (hARLP‐1) was the most prominent tumor‐associated AKR member detected in HCC by 2‐dimensional electrophoresis (2‐DE) and identified by mass spectrometric fingerprinting. The enzyme was found in 4 distinct forms (hARLP‐1, 36/7.4 (kd/pI); hARLP‐2, 36/7.2; hARLP‐3, 36/6.4; and hARLP‐4, 33/7.35). In addition, a human aldose reductase‐like protein (hARLP‐5, 36/7.6) was identified that differed from hARLP‐1 by 1 amino acid (D313N), indicating 2 allelic forms of the human aldose reductase‐like gene. A novel antibody directed against common parts of the hARLPs revealed hARLP reactivity in human HCC by immunohistochemistry. Furthermore, aldose reductase (AR) was identified and characterized as a tumor‐associated variant. In conclusion, in all investigated human HCCs at least one of the various types of the described tumor‐associated proteins of the AKR superfamily was clearly present. Of these HCC samples, 95% were positive for hARLPs as proven by 2‐DE analysis and/or by use of the antibody directed against hARLP. Thus, hARLP is a strong candidate for use as an immunohistochemical diagnostic marker of human HCC. (HEPATOLOGY 2004;39:540–549.)

[1]  S. Tsuchida,et al.  Glutathione transferases and cancer. , 1992, Critical reviews in biochemistry and molecular biology.

[2]  H. Rabes,et al.  Expression of tumor‐associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two‐dimensional electrophoresis , 1994, Electrophoresis.

[3]  A. Otto,et al.  Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. , 1994, The Journal of biological chemistry.

[4]  S. Hanash,et al.  Disease proteomics , 2003, Nature.

[5]  C. Ling,et al.  Isolation of differentially expressed aldose reductase in ovaries after estrogen withdrawal from hypophysectomized diethylstilbestrol treated rats: increased expression during apoptosis , 2000, Molecular and Cellular Endocrinology.

[6]  T. Benjamin,et al.  Micropreparative immobilized pH gradient two‐dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins , 1995, Electrophoresis.

[7]  P. Jungblut,et al.  A new method to assign immunodetected spots in the complex two‐dimensional electrophoresis pattern , 1997, Electrophoresis.

[8]  Hoguen Kim,et al.  Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma , 2002, International journal of cancer.

[9]  D. Harrison,et al.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. , 1999, The Biochemical journal.

[10]  R. Zeng,et al.  Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two‐dimensional electrophoresis and liquidchromatography‐ion trap mass spectrometry , 2000 .

[11]  P. Jungblut,et al.  Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting procedures. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[12]  R. Gani,et al.  Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases. , 2000, The Kobe journal of medical sciences.

[13]  H. Lee,et al.  Nuclear matrix of calreticulin in hepatocellular carcinoma. , 2000, Cancer research.

[14]  F. X. Bosch,et al.  Policy forum: public health. Reducing liver cancer--global control of aflatoxin. , 1999, Science.

[15]  E. Maser,et al.  Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. , 1995, Biochemical pharmacology.

[16]  M. Chung,et al.  Proteome database of hepatocellular carcinoma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  N. Anderson,et al.  Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. , 1978, Analytical biochemistry.

[18]  H. Jörnvall,et al.  Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Jungblut,et al.  Proteome analysis of rat hepatomas: Carcinogen‐dependent tumor‐associated protein variants , 2001, Electrophoresis.

[20]  J. Klose,et al.  Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. , 1999, Methods in molecular biology.

[21]  M McCarthy,et al.  Hepatology , 1999, Rapid Medicine.

[22]  Maxey C M Chung,et al.  Hepatocellular carcinoma: From bedside to proteomics , 2001, Proteomics.

[23]  T. Flynn,et al.  A new nomenclature for the aldo-keto reductase superfamily. , 1997, Biochemical pharmacology.

[24]  Laura Beretta,et al.  A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis* , 2002, Molecular & Cellular Proteomics.

[25]  T. Flynn,et al.  The aldo-keto reductases and their role in cancer. , 1999, Advances in experimental medicine and biology.

[26]  L. Qin,et al.  The prognostic molecular markers in hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[27]  Julia Martin,et al.  Pattern , 2005, The Fairchild Books Dictionary of Fashion.

[28]  S. Chung,et al.  Overexpression of aldose reductase in liver cancers may contribute to drug resistance , 2001, Anti-cancer drugs.

[29]  O. Hayaishi,et al.  A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes. , 1989, Experimental eye research.

[30]  B. Maleeff,et al.  Two‐dimensional electrophoresis of liver proteins: Characterization of a drug‐induced hepatomegaly in rats , 2000 .

[31]  M. Schwab,et al.  Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells. , 1998, Cancer research.

[32]  Joachim Klose,et al.  Two‐dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome , 1995, Electrophoresis.

[33]  F. X. Bosch,et al.  Reducing Liver Cancer--Global Control of Aflatoxin , 1999, Science.

[34]  Sheung Tat Fan,et al.  Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.

[35]  S. Hanash Disease proteomics : Proteomics , 2003 .

[36]  G. Auer,et al.  Cancer proteomics: From identification of novel markers to creation of artifical learning models for tumor classification , 2000, Electrophoresis.

[37]  P. Wirth Two‐dimensional polyacrylamide gel electrophoresis in experimental hepatocarcinogenesis studies , 1994, Electrophoresis.

[38]  E. Ren,et al.  Two‐dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC‐M, and identification of the separated proteins by mass spectrometry , 2000, Electrophoresis.

[39]  P. Bannasch Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. , 1996, Progress in liver diseases.

[40]  D. Greene,et al.  Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. , 1993, The American journal of physiology.

[41]  H. Rabes,et al.  Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE). , 1992, Carcinogenesis.

[42]  N. Taniguchi,et al.  Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: Implication in detoxification of cytotoxic aldehydes , 1995, International journal of cancer.

[43]  A. Otto,et al.  Further characterization of a rat hepatoma-derived aldose-reductase-like protein--organ distribution and modulation in vitro. , 1997, European journal of biochemistry.

[44]  W. Anderson,et al.  New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma , 1998, Hepatology.

[45]  R. Zeng,et al.  Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. , 2000, Electrophoresis.

[46]  T. Flynn,et al.  Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. , 1998, Biochimica et biophysica acta.

[47]  P. Shapiro,et al.  Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases , 2002, Anti-cancer drugs.

[48]  J. Hayes,et al.  An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Sung Gyoo Park,et al.  Proteome analysis of hepatocellular carcinoma. , 2002, Biochemical and biophysical research communications.

[50]  R. Seifert,et al.  Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. , 1990, Journal of biochemical and biophysical methods.

[51]  P. Kador,et al.  The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). , 2001, Chemico-biological interactions.

[52]  Jung Eun Shim,et al.  An integrated proteome database for two‐dimensional electrophoresis data analysis and laboratory information management system , 2002, Proteomics.

[53]  N G Anderson,et al.  Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. , 1978, Analytical biochemistry.

[54]  Nam-Gyun Kim,et al.  Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma , 2002, Hepatology.

[55]  N. Anderson,et al.  Analytical techniques for cell fractions , 1969 .

[56]  L. Schwartz,et al.  Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats. , 2000, Electrophoresis.